ALLIED HEALTHCARE PRODUCTS INC: Nasdaq/NYSE listing notice — Allied Healthcare approves asset disposal; Nasdaq delisting effective Feb 3

ALLIED HEALTHCARE PRODUCTS INC

Board approved plan to dispose of all or substantially all assets; Morris Anderson engaged to manage sale.
Estimated $17.5M multiemployer pension withdrawal liability from prior reduction in force.
Other liabilities: $865K loan from North Mill Capital and $14.7M rent due on lease through remaining term.
Nasdaq delisting due to failure to file Q3 Form 10-Q and no compliance plan; delisting effective Feb 3, 2023.
2022 Annual Meeting of Stockholders postponed indefinitely.

item 2.05 item 2.06 item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ALLIED HEALTHCARE PRODUCTS INC received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

January 25, 2023, Nasdaq notified the Company that, because of the Company’s failure to submit a compliance plan and its inability to file the late quarterly report, it has determined to delist the stock. The Company does not intend to appeal this decision and the delisting is expected to be effective at the opening of business on February 3, 2023, at which time trading in the Company’s stock will be suspended.

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-23-006940

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.